# Lingmou Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lingmou-medical

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.lynmou.com
- Latest round: Series A (Apr 7, 2025)
- Investors on record: 3

## About

Established in 2021 and based in Hangzhou, China, Lingmou Medical operates as an endoscopic product developer that mainly provides flexible endoscopy department-level solution. It has a R&D center in Shenzhen and a manufacturing center in Hangzhou. The company's self-developed electronic upper and lower gastrointestinal endoscopic scopes product was approved for marketing in April 2024. In April 2025, it closed series A funding led by new investor Unity Ventures.

The company focuses on the development and manufacture of endoscopic equipment. Products include imaging platforms and endoscopic products. Imaging platforms include VC-1600 and VC-880. Endoscopic products include electronic upper gastrointestinal endoscopes and electronic lower gastrointestinal endoscopes. Lower gastrointestinal endoscopes include extended enteroscopes, therapeutic colonoscopes, and sigmoidoscopes. Its products are mainly used in the field of gastroenterology.

The company generates revenue by providing endoscopic systems and devices.

The company will use the series A funding to accelerate the commercialization and academic promotion of its flexible endoscope system at home and abroad, and strengthen and supplement the company's endoscope product portfolio. It will further accelerate the overseas launch of its products.

## Funding rounds

- Series A, Apr 7, 2025 — Unity Ventures, CS Capital, Haibang Venture

## Investors

- Unity Ventures (https://capitalatlas.ai/funds/unity-ventures) — Series A
- CS Capital — Series A
- Haibang Venture — Series A